
Healthcare Distribution Market by Type (Biopharmaceutical Product Distribution Services, Medical Device Distribution Services, Pharmaceutical Product Distribution Services), End User (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
Description
Healthcare Distribution Market by Type (Biopharmaceutical Product Distribution Services, Medical Device Distribution Services, Pharmaceutical Product Distribution Services), End User (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
The Healthcare Distribution Market size was estimated at USD 1.19 trillion in 2023 and expected to reach USD 1.27 trillion in 2024, at a CAGR 7.44% to reach USD 1.97 trillion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Healthcare Distribution Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Healthcare Distribution Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Healthcare Distribution Market, highlighting leading vendors and their innovative profiles. These include AmerisourceBergen Corporation, Bastian Solutions, LLC, Cardinal Health, Inc., Dakota Drug Inc., DCH Auriga, Entero Healthcare, Evernorth Health Inc., FFF Enterprises, Inc., Henry Schein, Inc., MCKESSON CORPORATION, Morris & Dickson Co. LLC, Owens & Minor, Patterson Companies, Inc., Smith Drug Company, and ZETES Industries S.A..
Market Segmentation & Coverage
This research report categorizes the Healthcare Distribution Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Biopharmaceutical Product Distribution Services
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Medical Device Distribution Services
Pharmaceutical Product Distribution Services
Brand-Name
Generic Drugs
OTC Drugs
End User
Hospital Pharmacies
Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Healthcare Distribution Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Healthcare Distribution Market?
3. What are the technology trends and regulatory frameworks in the Healthcare Distribution Market?
4. What is the market share of the leading vendors in the Healthcare Distribution Market?
5. Which modes and strategic moves are suitable for entering the Healthcare Distribution Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Healthcare Distribution Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rise in the distribution of medical devices and pharmaceutical industry
- 5.1.1.2. Increasing incidences of chronic illness and surgeries
- 5.1.1.3. Favorable investment in R&D activities and growing development of new drugs
- 5.1.2. Restraints
- 5.1.2.1. Increasing pricing pressure on the major players in the healthcare industry
- 5.1.3. Opportunities
- 5.1.3.1. Implementation of track and trace systems and integration of RFID technologies, analytics, to streamline the healthcare distribution
- 5.1.3.2. Potential demand of growing biosimilars in economies
- 5.1.4. Challenges
- 5.1.4.1. Possibility of disruption due to bottlenecks
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Healthcare Distribution Market, by Type
- 6.1. Introduction
- 6.2. Biopharmaceutical Product Distribution Services
- 6.3.1. Monoclonal Antibodies
- 6.3.2. Recombinant Proteins
- 6.3.3. Vaccines
- 6.3. Medical Device Distribution Services
- 6.4. Pharmaceutical Product Distribution Services
- 6.5.1. Brand-Name
- 6.5.2. Generic Drugs
- 6.5.3. OTC Drugs
- 7. Healthcare Distribution Market, by End User
- 7.1. Introduction
- 7.2. Hospital Pharmacies
- 7.3. Retail Pharmacies
- 8. Americas Healthcare Distribution Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Healthcare Distribution Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Healthcare Distribution Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. AmerisourceBergen Corporation
- 12.1.2. Bastian Solutions, LLC
- 12.1.3. Cardinal Health, Inc.
- 12.1.4. Dakota Drug Inc.
- 12.1.5. DCH Auriga
- 12.1.6. Entero Healthcare
- 12.1.7. Evernorth Health Inc.
- 12.1.8. FFF Enterprises, Inc.
- 12.1.9. Henry Schein, Inc.
- 12.1.10. MCKESSON CORPORATION
- 12.1.11. Morris & Dickson Co. LLC
- 12.1.12. Owens & Minor
- 12.1.13. Patterson Companies, Inc.
- 12.1.14. Smith Drug Company
- 12.1.15. ZETES Industries S.A.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. HEALTHCARE DISTRIBUTION MARKET RESEARCH PROCESS
- FIGURE 2. HEALTHCARE DISTRIBUTION MARKET SIZE, 2023 VS 2030
- FIGURE 3. HEALTHCARE DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. HEALTHCARE DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. HEALTHCARE DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. HEALTHCARE DISTRIBUTION MARKET DYNAMICS
- FIGURE 7. HEALTHCARE DISTRIBUTION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. HEALTHCARE DISTRIBUTION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. HEALTHCARE DISTRIBUTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 10. HEALTHCARE DISTRIBUTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS HEALTHCARE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS HEALTHCARE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES HEALTHCARE DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES HEALTHCARE DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC HEALTHCARE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC HEALTHCARE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. HEALTHCARE DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. HEALTHCARE DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.